BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
T cell differentiation
,
Obesity
,
Kidney
,
Nosology
,
Lipitor
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
multidrug resistance associated protein-2
Summary
General Info
Curated Studies
Most Correlated Studies
Kidney-specific Dysfunction of MRP2 (ABCC2) and the Functional Consequences for Renal Grafts
Explore Curated Studies Results
Literature
Most Relevant Literature
ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WH…
The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia.
ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib.
Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Re…
Characterization of a novel ABCC2 mutation in infantile Dubin Johnson syndrome.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
The Pharmacological Effects of Using Cabozantinib With a Light Breakfast
Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease
Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers
Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ